Overview
- Graham, in a Marie Claire interview published Monday, said GLP-1‑driven thinness is undoing runway progress for larger bodies.
- About 1 in 8 U.S. adults has used a GLP-1 for diabetes, heart disease or weight loss, according to USA TODAY.
- GLP-1 medicines help control blood sugar in people with Type 2 diabetes, and some versions are cleared for chronic weight management.
- Ozempic is approved for diabetes treatment, while Wegovy and Mounjaro are approved for long‑term weight loss, according to reporting that cites medical guidance.
- Experts warn that wider access, including new weight‑loss pills, could revive diet‑culture pressure, though Graham says plus‑size representation and creators will continue to grow.